Published in Free Radic Biol Med on February 24, 2010
Aging and the aggregating proteome. Front Genet (2012) 0.97
Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: implications for oxidative stress and insolubility of newly synthesized proteins. Free Radic Biol Med (2010) 0.88
Amino acid analog toxicity in primary rat neuronal and astrocyte cultures: implications for protein misfolding and TDP-43 regulation. J Neurosci Res (2011) 0.78
Mechanisms underlying ubiquitination. Annu Rev Biochem (2001) 18.87
Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem (1996) 10.70
Proteasomes: destruction as a programme. Trends Biochem Sci (1996) 3.15
Molecular pathways to neurodegeneration. Nat Med (2004) 2.94
Degradation of oxidized proteins by the 20S proteasome. Biochimie (2001) 2.93
Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci (2001) 2.63
Degradation of oxidized proteins in mammalian cells. FASEB J (1997) 2.51
Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann Neurol (1999) 2.42
Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci U S A (2009) 2.22
Protein stability and resistance to oxidative stress are determinants of longevity in the longest-living rodent, the naked mole-rat. Proc Natl Acad Sci U S A (2009) 2.14
Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol Chem (2008) 1.80
Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J Biol Chem (1996) 1.75
Aging and oxidative stress: modulation by dietary restriction. Free Radic Biol Med (1996) 1.74
Role of proteasomes in disease. BMC Biochem (2007) 1.65
The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J Cell Biochem Suppl (2000) 1.61
Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol (2004) 1.57
Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res (2007) 1.54
Oxidative stress and protein aggregation during biological aging. Exp Gerontol (2001) 1.49
Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems. Proc Natl Acad Sci U S A (1997) 1.42
Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol (2002) 1.40
Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience (2000) 1.40
Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. J Biol Chem (1993) 1.38
Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid Redox Signal (2006) 1.33
Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem (2004) 1.27
The long lifespan of two bat species is correlated with resistance to protein oxidation and enhanced protein homeostasis. FASEB J (2009) 1.22
Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J (2006) 1.20
In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic Biol Med (2009) 1.20
Age-related neuropathology, cognitive decline, and Alzheimer's disease. Ageing Res Rev (2005) 1.19
Protein oxidation and cellular homeostasis: Emphasis on metabolism. Biochim Biophys Acta (2006) 1.19
Proteasomal defense of oxidative protein modifications. Antioxid Redox Signal (2006) 1.18
Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction. Trends Neurosci (2001) 1.14
Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech Ageing Dev (2001) 1.10
Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. Prog Neurobiol (2004) 1.10
Carbonic anhydrase III. Oxidative modification in vivo and loss of phosphatase activity during aging. J Biol Chem (1995) 1.08
Macroxyproteinase (M.O.P.): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radic Biol Med (1989) 1.05
Deterioration of spatial and nonspatial reference and working memory in aged rats: protective effect of life-long calorie restriction. Neurobiol Aging (1992) 1.04
Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. Arch Biochem Biophys (1994) 1.04
Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle. FEBS Lett (2002) 1.03
Protein oxidation and degradation during postmitotic senescence. Free Radic Biol Med (2005) 1.00
Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease. Curr Med Chem (2001) 1.00
Proteolysis, caloric restriction and aging. Mech Ageing Dev (2001) 0.99
Inactivation of enzymes and oxidative modification of proteins by stimulated neutrophils. Arch Biochem Biophys (1987) 0.97
Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II--aging of nondividing cells. FASEB J (2000) 0.96
Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Curr Alzheimer Res (2007) 0.95
4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease. Cell Mol Life Sci (2000) 0.93
A novel approach for screening the proteome for changes in protein conformation. Biochemistry (2006) 0.92
Beneficial biochemical outcomes of late-onset dietary restriction in rodents. Ann N Y Acad Sci (2007) 0.91
Inverse correlation of protein oxidation and proteasome activity in liver and lung. Mech Ageing Dev (2009) 0.90
Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction. Mech Ageing Dev (1998) 0.89
Studies on the activation by ATP of the 26 S proteasome complex from rat skeletal muscle. Biochem J (1995) 0.89
Protein oxidation and degradation during aging: role in skin aging and neurodegeneration. Free Radic Res (2006) 0.88
Heat shock and oxidative stress-induced exposure of hydrophobic protein domains as common signal in the induction of hsp68. J Biol Chem (2000) 0.87
Comparison of rat liver and brain proteasomes for oxidative stress-induced inactivation: Influence of ageing and dietary restriction. Free Radic Res (2009) 0.86
Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidants. Biochem Biophys Res Commun (2005) 0.86
Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease. Neurol Res (2008) 0.83
The beneficial effects of dietary restriction: reduced oxidative damage and enhanced apoptosis. Mutat Res (1996) 0.83
Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A (2004) 5.65
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci (2002) 3.11
TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol (2007) 2.97
Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol (2009) 2.87
Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol (2002) 2.68
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol (2006) 2.43
Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord (2006) 2.26
Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiol Aging (2006) 2.23
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med (2002) 2.10
Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med (2002) 2.08
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis (2006) 2.04
Methodological Considerations in Studying Centenarians: Lessons Learned From the Georgia Centenarian Studies. Annu Rev Gerontol Geriatr (2007) 1.85
Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol (2009) 1.82
Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet. Neurobiol Dis (2009) 1.80
Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci (2005) 1.80
Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol (2003) 1.73
Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol (2009) 1.73
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem (2002) 1.73
Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem (2003) 1.70
Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol Aging (2005) 1.66
Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. J Neuropathol Exp Neurol (2009) 1.66
Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res (2007) 1.62
Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging (2005) 1.60
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis (2005) 1.58
Modulation of CREB activity by the Rho GTPase regulates cell and organism size during mouse embryonic development. Dev Cell (2002) 1.58
Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp Neurol (2008) 1.58
RNA in brain disease: no longer just "the messenger in the middle". J Neuropathol Exp Neurol (2007) 1.57
Histone H4 lysine 16 hypoacetylation is associated with defective DNA repair and premature senescence in Zmpste24-deficient mice. Proc Natl Acad Sci U S A (2011) 1.56
Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res (2007) 1.54
HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia (2006) 1.53
Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat Neurosci (2011) 1.53
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem (2006) 1.52
In silico cancer modeling: is it ready for prime time? Nat Clin Pract Oncol (2008) 1.52
Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging (2005) 1.52
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol Aging (2005) 1.50
Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment. Nucleic Acids Res (2007) 1.48
Molecular footprints of domestication and improvement in soybean revealed by whole genome re-sequencing. BMC Genomics (2013) 1.46
Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim Biophys Acta (2008) 1.46
High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling. J Neurochem (2010) 1.43
Growth factor mediated assembly of cell receptor-responsive hydrogels. J Am Chem Soc (2007) 1.42
Heat stress-induced response of the proteomes of leaves from Salvia splendens Vista and King. Proteome Sci (2013) 1.41
Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. Neurobiol Dis (2007) 1.40
Association of estrogen receptor gene polymorphisms with susceptibility to adolescent idiopathic scoliosis. Spine (Phila Pa 1976) (2006) 1.40
Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis (2008) 1.38
Association of selected persistent organic pollutants in the placenta with the risk of neural tube defects. Proc Natl Acad Sci U S A (2011) 1.38
Indoor air pollution from coal combustion and the risk of neural tube defects in a rural population in Shanxi Province, China. Am J Epidemiol (2011) 1.36
Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain. J Neurosci (2003) 1.35
A population-based case-control study of risk factors for neural tube defects in four high-prevalence areas of Shanxi province, China. Paediatr Perinat Epidemiol (2006) 1.33
Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid Redox Signal (2006) 1.33
Obesity and vulnerability of the CNS. Biochim Biophys Acta (2008) 1.29
Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. Am J Pathol (2006) 1.28
Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem (2004) 1.27
Simulating non-small cell lung cancer with a multiscale agent-based model. Theor Biol Med Model (2007) 1.25
Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR. Basic Res Cardiol (2011) 1.24
Designing a large prevention trial: statistical issues. Stat Med (2004) 1.24
NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal (2010) 1.22
Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation. J Neurochem (2008) 1.22
Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res (2009) 1.22
Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res (2007) 1.21
Saturated long-chain fatty acids activate inflammatory signaling in astrocytes. J Neurochem (2012) 1.21
Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription. PLoS One (2008) 1.21
Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol (2006) 1.21
Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease. Neurochem Res (2006) 1.21
Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J (2006) 1.20
Cytochrome c release and caspase activation after traumatic brain injury. Brain Res (2002) 1.20
Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic Biol Med (2008) 1.19
Life Sciences and the web: a new era for collaboration. Mol Syst Biol (2008) 1.19
Protein oxidation and cellular homeostasis: Emphasis on metabolism. Biochim Biophys Acta (2006) 1.19
Characterization of chronic low-level proteasome inhibition on neural homeostasis. J Neurochem (2003) 1.18
Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000. Cerebrovasc Dis (2004) 1.17
Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction. Aging (Albany NY) (2010) 1.16
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging (2010) 1.16
Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment. Neurosci Lett (2008) 1.15
Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biol Pharm Bull (2008) 1.15
The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochim Pol (2003) 1.14
Rheological characterization of polysaccharide-poly(ethylene glycol) star copolymer hydrogels. Biomacromolecules (2005) 1.14
Kalirin is under-expressed in Alzheimer's disease hippocampus. J Alzheimers Dis (2007) 1.14
Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med (2012) 1.13
Oxidative stress in head trauma in aging. Free Radic Biol Med (2006) 1.13
Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model. Nat Commun (2013) 1.12
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development. Neuromolecular Med (2003) 1.11